Compare MYRG & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYRG | RLAY |
|---|---|---|
| Founded | 1891 | 2015 |
| Country | United States | United States |
| Employees | 9000 | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 4.1B |
| IPO Year | 2008 | 2020 |
| Metric | MYRG | RLAY |
|---|---|---|
| Price | $390.93 | $19.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $262.43 | $19.50 |
| AVG Volume (30 Days) | 303.0K | ★ 4.2M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 311.48 | 31.78 |
| EPS | ★ 2.99 | N/A |
| Revenue | ★ $1,531,169,000.00 | $15,355,000.00 |
| Revenue This Year | $11.87 | N/A |
| Revenue Next Year | $8.48 | $324.03 |
| P/E Ratio | $132.76 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $171.51 | $3.03 |
| 52 Week High | $503.57 | $20.79 |
| Indicator | MYRG | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 36.42 | 62.76 |
| Support Level | $251.81 | $12.10 |
| Resistance Level | $485.92 | $20.79 |
| Average True Range (ATR) | 22.13 | 1.31 |
| MACD | -7.30 | -0.09 |
| Stochastic Oscillator | 12.91 | 73.40 |
MYR Group Inc is a U.S. based holding company of specialty electrical construction service providers. Through its subsidiaries, it serves electric utility, commercial, and industrial construction markets in the United States and Canada, offering services such as design, engineering, procurement, construction, upgrades, maintenance, and repair, with a focus on construction, maintenance, and repair work. The company operates through two segments: Transmission and Distribution (T&D) and Commercial and Industrial (C&I). The majority of revenue is derived from the T&D segment, which provides a range of services on electric transmission and distribution networks and substation facilities, which include design, engineering, procurement, construction, upgrade and maintenance and repair services.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.